Where does Teva Branded Pharmaceutical Products R&D, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Teva Branded Pharmaceutical Products R&D, Inc. ranks #21,889 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Teva Branded Pharmaceutical Products R&D, Inc. hold?

Teva Branded Pharmaceutical Products R&D, Inc. holds 13 US utility patents granted between 2015 and 2021, spanning 5 technology areas.

What is Teva Branded Pharmaceutical Products R&D, Inc.'s Innovation Score?

Teva Branded Pharmaceutical Products R&D, Inc. has an Innovation Score of 25.4 out of 100 (17th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Teva Branded Pharmaceutical Products R&D, Inc. focus on?

Teva Branded Pharmaceutical Products R&D, Inc.'s top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 9 patents, ranking #2,395 of 7,163 assignees active in that subclass. Grants appear in 5 CPC subclasses total.

Is Teva Branded Pharmaceutical Products R&D, Inc.'s patent grant rate increasing or decreasing?

Teva Branded Pharmaceutical Products R&D, Inc.'s recent grant velocity is -37% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Teva Branded Pharmaceutical Products R&D, Inc.'s patents?

Teva Branded Pharmaceutical Products R&D, Inc.'s patents average 13.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

USPTO 2015–2025 USPTO PatentsView US Corporation

Teva Branded Pharmaceutical Products R&D, Inc.

Q: How is the Teva Branded Pharmaceutical Products R&D, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO PatentsView assignee record - 13 granted patents across 5 technology areas, recorded in grant years 2015–2021. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Teva ranks #21,889 of 49,997 tracked US assignees by granted-patent volume, with 13 patents across 5 technology areas.

#21,889
of 49,997 US assignees by volume: 17th percentile
by Innovation Score (25.4/100): 13.9
avg claims per patent: -37%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R21889 · US Corporation #21,889 · 13 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-DOWN · BOOK-FULL

GRANTS-MICRO 13 grants
MID-PACK #21,889/49,997
PHOTO-FINISH Teramount
CPC-NARROW A61K · 5 areas
INNOV-THIN 25.4/100
CLAIMS-RICH 13.9 claims/avg
TYPE-USCORP US Corporation
VEL-DOWN -37% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Teramount Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Teva’s 25.4 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.1 pts (36%) Velocity 0.0 pts (0%) Breadth 7.9 pts (31%) Claim depth 8.4 pts (33%)

Qualcomm Incorporated · highest

85
Teva Branded… · this assignee

25
3D Lighting… · lowest

7

What this shows Teva's Innovation Score is 25.4/100 (17th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Teva?

Each dot is one of Teva’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Teva’s own 13.9 claims/patent is at or below the 16.2 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Teva vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Teva's grants concentrate

Teva Branded Pharmaceutical Products R&D, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 69.2% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2021 (3 grants) versus a trough of 1 in 2015. By volume, Teva sits between Teramount Ltd. and The Metraflex Company.

Teramount

13
Terra Quantum

13
Terumo BCT Biotec…

13
Testcard

13
The Armor All/STP…

13
The Board of Trus…

13
The Clearing Hous…

13
The Metraflex

13
Teva Branded Phar… ◀

13

What this shows Teva holds 13 patents at rank #21,925, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Teva

By rank, the assignees closest to #21,925 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Teva's primary technology class.

Teva's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

25 17th percentile higher than 17% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2021

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Teva Branded Pharmaceutical Products R&D, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.7%
2016	2	15.4%
2017	2	15.4%
2018	2	15.4%
2019	1	7.7%
2020	2	15.4%
2021	3	23.1%

Which technologies does Teva Branded Pharmaceutical Products R&D, Inc. patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 9

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 8

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 7

B65D - Containers FOR Storage OR Transport OF Articles OR Materials, e.g. Bags, Barrels, Bottles, Boxes, Cans, Cartons, Crates, Drums, Jars, Tanks, Hoppers, Forwarding CONTAINERS; Accessories, Closures, OR Fittings THEREFOR; Packaging ELEMENTS; Packages 1

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

Top 5 of 5 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Teva Branded Pharmaceutical Products R&D, Inc.'s patent record in context - here's where to go next.

Teva Branded Pharmaceutical Products R&D, Inc.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 69.2% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #21,889 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Teva Branded Pharmaceutical Products R&D, Inc. against Teramount Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 25.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.